Guardant Health, INC Form 4 insider transactions

Meghan V. Joyce, a director at Guardant Health, Inc., executed stock options on August 4, 2024, acquiring 66 shares of common stock.

Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

Manuel Hidalgo Medina, a director of Guardant Health, Inc., reported the acquisition of stock options and restricted stock units on July 17, 2024.

Director Tariq Musa reported the vesting and disposal of restricted stock units in Guardant Health, Inc.

Director Myrtle S. Potter reports the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition of 66 shares of common stock on July 4, 2024, through the vesting of restricted stock units.

John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the acquisition and disposal of common stock related to restricted stock units.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

AmirAli Talasaz, Co-CEO of Guardant Health, reports the acquisition and disposal of common stock related to restricted stock unit vesting.

Director Steve Krognes reported the vesting and conversion of restricted stock units into common stock of Guardant Health, Inc.

Helmy Eltoukhy, Co-CEO of Guardant Health, reports the vesting of restricted stock units and associated tax withholding.

Director Tariq Musa reports the disposition of common stock and restricted stock units in Guardant Health, Inc.

John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Director Myrtle S. Potter reports the acquisition of 68 shares of Guardant Health, Inc. common stock on June 15, 2024, through the vesting of restricted stock units.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the acquisition and disposal of company stock related to restricted stock units.

Chief Commercial Officer Chris Freeman reports acquisition and disposal of Guardant Health stock and restricted stock units due to vesting and tax obligations.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the acquisition and disposal of common stock related to the vesting of restricted stock units.

Michael Brian Bell, CFO of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Director Tariq Musa of Guardant Health, Inc. reports acquisition of stock options and restricted stock units.

Director Myrtle S. Potter reports acquisition and disposal of Guardant Health stock and derivative securities.

Director Steve Krognes reports acquisition and disposal of Guardant Health stock and derivative securities.

Director Meghan V. Joyce of Guardant Health, Inc. reports the acquisition and disposal of common stock and derivative securities.

Director Vijaya Gadde reported the acquisition and disposal of Guardant Health, Inc. stock and derivative securities.

Director Ian T. Clark reports transactions involving Guardant Health stock, including the vesting and disposal of restricted stock units and the grant of stock options.

Director Meghan Joyce reports the acquisition and disposition of Guardant Health (GH) common stock on June 4, 2024, including sales under a pre-arranged 10b5-1 plan.

John G. Saia, Chief Legal Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Kumud Kalia, Chief Information Officer of Guardant Health, reports stock transactions including the vesting of restricted stock units and shares acquired under the Employee Stock Purchase Plan.